Back to All Events

Oncology Drug Advisory Committee ([ODAC])

  • IQVIA Solutions Denmark A/S Denmark (map)

On Thursday, March 9, 2023, the ODAC will discuss sBLA for POLIVY (polatuzumab vedotin-piiq) injection submitted by Genentech for use in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone for the treatment of adult patients with previously untreated DLBCL.

Source:: https://www.fda.gov/advisory-committees/advisory-committee-calendar/march-9-2023-meeting-oncologic-drugs-advisory-committee-meeting-announcement-03092023
Earlier Event: March 7
Vaccines and Related Biological Products Advisory Committee (VRBPAC)
Later Event: March 16
Antimicrobial Drugs Advisory Committee